HealthWell Foundation — Non-Small Cell Lung Cancer — Medicare Access Fund

Copay assistance fund status, eligibility, and covered drugs — for patient access and billing teams.

Maximum award Average patient uses ~$2,500/year · Income ≤500% FPL, adjusted for household size · Pharmacy card for prescription drug copays — covers drug only

OPEN
Status verified June 3, 2026 · Source: HealthWell Foundation fund page ↗
Closed to new patients due to insufficient funding. Existing grant holders remain active for full 12-month cycle.

Fund facts

Published terms from the foundation. Per-patient eligibility and amounts are confirmed at application.

Assistance type
Copay Grant
Maximum award
Average patient uses ~$2,500/year
What it covers
Pharmacy card for prescription drug copays — covers drug only
Income limit
≤500% FPL, adjusted for household size
Insurance
medicare no medicaid
Diagnosis required
Non-small cell lung cancer
Residency
US resident receiving treatment in US
ICD-10
C34.00 C34.10 C34.30 C34.90 C34.91
Processing time
5–10 business days
Renewal
annual reapplication
Currently waitlist. Daily cron monitors for reopening.

Covered drugs in our billing library

Drugs whose J-codes this fund matches. Each links to its billing & coding reference.

Published formulary

The foundation's own covered-medication list for this fund (130 drugs). Confirm coverage of your exact NDC at application.

Show all 130 covered medications
  • Abraxane
  • Afatinib Dimaleate
  • Alecensa
  • Alimta
  • Alunbrig
  • Alymsys
  • Atezolizumab
  • Augtyro
  • Avastin
  • Avgemsi
  • Axtle
  • Bevacizumab
  • Bevacizumab-awwb
  • Bevacizumab-nwgd
  • Braftovi
  • Brigatinib
  • Cabometyx
  • Camptosar
  • Carboplatin
  • Ceenu
  • Ceritinib
  • Cetuximab
  • Cisplatin
  • Cometriq
  • Crizotinib
  • Cyramza
  • Docetaxel
  • Docivyx
  • Doxorubicin Hydrochloride
  • Durvalumab
  • Ellence
  • Emrelis
  • Enhertu
  • Ensacove
  • Entrectinib
  • Epirubicin
  • Erbitux
  • Erlotinib
  • Erlotinib Hydrochloride
  • Etopophos
  • Etoposide
  • Exkivity
  • Gavreto
  • Gemcitabine Hydrochloride
  • Gemzar
  • Gilotrif
  • Gleostine
  • Herceptin
  • Hernexeos
  • Herzuma
  • Hycamtin
  • Hyrnuo
  • Ibtrozi
  • Ifex
  • Imfinzi
  • Imjudo
  • Ipilimumab
  • Iressa
  • Irinotecan
  • Jobevne
  • Kanjinti
  • Keytruda
  • Keytruda Qlex
  • Krazati
  • Lazcluze
  • Lazertinib
  • Libtayo
  • Lomustine
  • Lorbrena
  • Lorlatinib
  • Lumakras
  • Mechlorethamine Hydrochloride
  • Mekinist
  • Mesnex
  • Methotrexate
  • Methotrexate Lpf
  • Mustargen
  • Mvasi
  • Navelbine
  • Nexavar
  • Nivolumab
  • Ontruzant
  • Opdivo
  • Opdivo Qvantig
  • Osenvelt
  • Paclitaxel
  • Paraplatin
  • Pembrolizumab
  • Pemetrexed
  • Pemetrexed Disodium
  • Pemfexy
  • Pemrydi Rtu
  • Photofrin
  • Platinol
  • Platinol-aq
  • Portrazza
  • Ramucirumab
  • Retevmo
  • Rozlytrek
  • Rybrevant
  • Rybrevant Faspro
  • Sevabertinib
  • Sutent
  • Tabrecta
  • Tafinlar
  • Tagrisso
  • Tarceva
  • Taxol
  • Taxotere
  • Tecentriq
  • Tecentriq Hebreza
  • Tepmetko
  • Thalomid
  • Trastuzumab-qyyp
  • Trazimera
  • Tremelimumab-actl
  • Vegzelma
  • Vinblastine Sulfate
  • Vinorelbine Tartrate
  • Vizimpro
  • Wyost
  • Xalkori
  • Xgeva
  • Yervoy
  • Zelboraf
  • Zirabev
  • Zoledronic Acid
  • Zometa
  • Zongertinib
  • Zykadia

This fund is open — what will your patient owe?

Run a Medicare estimate for a covered drug in about a minute. The fund's award caps against the patient share CareCost calculates.

Common questions

Is the HealthWell Foundation Non-Small Cell Lung Cancer — Medicare Access fund open?

As of June 3, 2026, the HealthWell Foundation Non-Small Cell Lung Cancer — Medicare Access fund is OPEN and accepting applications. Verify at time of service: 800-675-8416.

How much assistance does the Non-Small Cell Lung Cancer — Medicare Access fund provide?

Average patient uses ~$2,500/year. Pharmacy card for prescription drug copays — covers drug only

What are the income limits for the Non-Small Cell Lung Cancer — Medicare Access fund?

Household income must be ≤500% FPL, adjusted for household size. US resident receiving treatment in US.

What insurance does the Non-Small Cell Lung Cancer — Medicare Access fund accept?

Accepted: medicare. Not eligible: medicaid.

How long does the Non-Small Cell Lung Cancer — Medicare Access fund take to process an application?

The foundation's published processing time is 5–10 business days. Renewal: annual reapplication.

Patient or caregiver? Show this page to your infusion center's financial counselor — they can check what you'd qualify for and apply on your behalf, or call HealthWell Foundation at 800-675-8416.